Further, levels of CCAT2 in nuclear and cytoplasmic fractionated U87-MG and U251 cells revealed that CCAT2 was mainly existed in the nucleus of glioma cells (more than 65%) (Figure 1C and 1D). This evidence concerns the gene CCAT2 and glioma.